Target
Serine/threonine-protein kinase 17A
Ligand
BDBM441881
Substrate
n/a
Meas. Tech.
Activity Inhibition Assay
IC50
22.0±n/a nM
Citation
 Lee, KChoi, GLee, NRPark, SJJung, MEKim, SJYang, KLee, J Substituted pyrimidines for preventing or treating cancer and inflammatory diseases US Patent  US10647686 Publication Date 5/12/2020 
Target
Name:
Serine/threonine-protein kinase 17A
Synonyms:
DRAK1 | ST17A_HUMAN | STK17A
Type:
Enzyme Catalytic Domain
Mol. Mass.:
46544.04
Organism:
Homo sapiens (Human)
Description:
gi_109255245
Residue:
414
Sequence:
MIPLEKPGSGGSSPGATSGSGRAGRGLSGPCRPPPPPQARGLLTEIRAVVRTEPFQDGYSLCPGRELGRGKFAVVRKCIKKDSGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYETASEMILVLEYAAGGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTRDVVHLDLKPQNILLTSESPLGDIKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMWSIGVLTYVMLTGISPFLGNDKQETFLNISQMNLSYSEEEFDVLSESAVDFIRTLLVKKPEDRATAEECLKHPWLTQSSIQEPSFRMEKALEEANALQEGHSVPEINSDTDKSETKESIVTEELIVVTSYTLGQCRQSEKEKMEQKAISKRFKFEEPLLQEIPGEFIY
  
Inhibitor
Name:
BDBM441881
Synonyms:
US10647686, Example (25)
Type:
Small organic molecule
Emp. Form.:
C17H24ClN7
Mol. Mass.:
361.872
SMILES:
NCCCNc1nc(Nc2ccc(cc2)N2CCNCC2)ncc1Cl
Structure:
Search PDB for entries with ligand similarity: